Amedeo Smart

Free Medical Literature Service


 

Amedeo

Lung Cancer

  Free Subscription

Articles published in
Arch Pathol Lab Med
    April 2024
  1. SUN Q, Li W, Yang D, Lin PP, et al
    The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in Non-Small Cell Lung Cancer Patients.
    Arch Pathol Lab Med. 2024 Apr 18. doi: 10.5858/arpa.2023-0455.
    >> Share

  2. SHOLL LM, Awad M, Basu Roy U, Beasley MB, et al
    Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International As
    Arch Pathol Lab Med. 2024 Apr 16. doi: 10.5858/arpa.2023-0536.
    >> Share

  3. MILLER LJ, Holmes IM, Lew M
    An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers.
    Arch Pathol Lab Med. 2024;148:409-418.
    >> Share

    March 2024
  4. BLATNIK A, Dragos VS, Blatnik O, Stegel V, et al
    A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period.
    Arch Pathol Lab Med. 2024;148:299-309.
    >> Share

    December 2023
  5. NAMBIRAJAN A, Sood R, Khatoon W, Malik PS, et al
    Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non-Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Ch
    Arch Pathol Lab Med. 2023 Dec 6. doi: 10.5858/arpa.2023-0229.
    >> Share

  6. HOCKING AJ, Thomas EM, Prabhakaran S, Jolley A, et al
    Molecular Characterization of Testicular Mesothelioma and the Role of Asbestos as a Causative Factor.
    Arch Pathol Lab Med. 2023;147:1446-1450.
    >> Share

    August 2023
  7. LECHNER A, Rai A, Rojas-Rudilla V, Kuang Y, et al
    Atypical Droplet Digital Polymerase Chain Reaction Patterns That Indicate Uncommon but Clinically Actionable EGFR Mutations in Lung Cancer.
    Arch Pathol Lab Med. 2023 Aug 28. doi: 10.5858/arpa.2023-0088.
    >> Share

  8. LAMI K, Bychkov A, Matsumoto K, Attanoos R, et al
    Overcoming the Interobserver Variability in Lung Adenocarcinoma Subtyping: A Clustering Approach to Establish a Ground Truth for Downstream Applications.
    Arch Pathol Lab Med. 2023;147:885-895.
    >> Share

    July 2023
  9. CHO WC, Vanderbeck K, Nagarajan P, Milton DR, et al
    SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
    Arch Pathol Lab Med. 2023;147:758-766.
    >> Share

    June 2023
  10. ELFVING H, Thurfjell V, Mattsson JSM, Backman M, et al
    Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies.
    Arch Pathol Lab Med. 2023 Jun 30. doi: 10.5858/arpa.2022-0327.
    >> Share

    March 2023
  11. BRCIC L, Le Stang N, Gallob F, Pissaloux D, et al
    A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.
    Arch Pathol Lab Med. 2023;147:313-322.
    >> Share

    February 2023
  12. NOVA-CAMACHO LM, Gomez-Dorronsoro M, Guarch R, Cordoba A, et al
    Cardiac Metastasis From Solid Cancers: A 35-Year Single-Center Autopsy Study.
    Arch Pathol Lab Med. 2023;147:177-184.
    >> Share

    January 2023
  13. KIM MY, Kim H, Sung JA, Koh J, et al
    Whole Mitochondrial Genome Analysis in Non-Small Cell Lung Carcinoma Reveals Unique Tumor-Specific Somatic Mutations.
    Arch Pathol Lab Med. 2023 Jan 5. doi: 10.5858/arpa.2022-0175.
    >> Share

    October 2022
  14. YAO Q, Bai Q, Zhang X, Ji G, et al
    Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing.
    Arch Pathol Lab Med. 2022;146:1234-1242.
    >> Share

    August 2022
  15. XU H, Fan F, Gong Y, Jing X, et al
    Diagnostic Challenges in Fine-Needle Aspiration Cytology of Mediastinal Tumors and Lesions.
    Arch Pathol Lab Med. 2022;146:960-974.
    >> Share

    June 2022
  16. MATA DA, Harries L, Williams EA, Hiemenz MC, et al
    Method of Tissue Acquisition Affects Success of Comprehensive Genomic Profiling in Lung Cancer.
    Arch Pathol Lab Med. 2022 Jun 30. pii: 483419. doi: 10.5858/arpa.2021-0313.
    >> Share

    March 2022
  17. BAKER JA, Sireci AN, Marella N, Cannon HK, et al
    Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization.
    Arch Pathol Lab Med. 2022;146:351-359.
    >> Share

    November 2021
  18. BERNICKER EH, Xiao Y, Croix DA, Yang B, et al
    Understanding Factors Associated With Anaplastic Lymphoma Kinase Testing Delays in Patients With Non-Small Cell Lung Cancer in a Large Real-World Oncology Database.
    Arch Pathol Lab Med. 2021 Nov 9. pii: 473659. doi: 10.5858/arpa.2021-0029.
    >> Share

  19. WANG M, Gilani S, Xu H, Cai G, et al
    Salivary Gland-type Tumors of the Lung.
    Arch Pathol Lab Med. 2021;145:1379-1386.
    >> Share

  20. LAWRENCE L, Kunder CA, Fung E, Stehr H, et al
    Performance Characteristics of Mutational Signature Analysis in Targeted Panel Sequencing.
    Arch Pathol Lab Med. 2021;145:1424-1431.
    >> Share

    October 2021
  21. KEPPENS C, Van Royen Y, Brysse A, Cotteret S, et al
    Incidents in Molecular Pathology: Frequency and Causes During Routine Testing.
    Arch Pathol Lab Med. 2021;145:1270-1279.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016